Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)
CNY 6.29
(1.78%)
CNY 6.29
(1.78%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 416.69 Million CNY | 77.77% |
| 2022 | 234.4 Million CNY | -44.97% |
| 2021 | 425.93 Million CNY | 16.79% |
| 2020 | 364.7 Million CNY | -25.08% |
| 2019 | 486.78 Million CNY | -14.82% |
| 2018 | 571.44 Million CNY | 7.1% |
| 2017 | 533.57 Million CNY | 18.02% |
| 2016 | 452.1 Million CNY | -21.38% |
| 2015 | 575.04 Million CNY | -17.27% |
| 2014 | 695.08 Million CNY | 20.38% |
| 2013 | 577.39 Million CNY | 20.04% |
| 2012 | 481.01 Million CNY | -8.09% |
| 2011 | 523.34 Million CNY | 91.9% |
| 2010 | 272.71 Million CNY | 11.72% |
| 2009 | 244.1 Million CNY | 12.05% |
| 2008 | 217.85 Million CNY | 61.62% |
| 2007 | 134.8 Million CNY | 167.88% |
| 2006 | 50.32 Million CNY | 48.78% |
| 2005 | 33.82 Million CNY | 5.68% |
| 2004 | 32 Million CNY | 2.57% |
| 2003 | 31.19 Million CNY | 61.71% |
| 2002 | 19.29 Million CNY | 2.06% |
| 2001 | 18.9 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 70.13 Million CNY | -29.25% |
| 2024 Q3 | -46.32 Million CNY | -14.26% |
| 2024 Q2 | -40.54 Million CNY | -157.81% |
| 2023 Q1 | 201.92 Million CNY | 3197.73% |
| 2023 Q2 | 115.23 Million CNY | -42.93% |
| 2023 Q3 | 403.95 Thousand CNY | -99.65% |
| 2023 Q4 | 99.12 Million CNY | 24438.4% |
| 2023 FY | 416.69 Million CNY | 77.77% |
| 2022 Q2 | 102.03 Million CNY | 61.2% |
| 2022 Q3 | 72.62 Million CNY | -28.83% |
| 2022 Q4 | -6.51 Million CNY | -108.98% |
| 2022 FY | 234.4 Million CNY | -44.97% |
| 2022 Q1 | 63.29 Million CNY | 732.89% |
| 2021 Q3 | 134.39 Million CNY | -35.91% |
| 2021 Q4 | -10 Million CNY | -107.44% |
| 2021 FY | 425.93 Million CNY | 16.79% |
| 2021 Q2 | 209.71 Million CNY | 128.37% |
| 2021 Q1 | 91.83 Million CNY | 49.38% |
| 2020 Q3 | 106.45 Million CNY | -21.26% |
| 2020 Q1 | 61.58 Million CNY | 478.76% |
| 2020 Q2 | 135.19 Million CNY | 119.54% |
| 2020 Q4 | 61.47 Million CNY | -42.26% |
| 2020 FY | 364.7 Million CNY | -25.08% |
| 2019 FY | 486.78 Million CNY | -14.82% |
| 2019 Q2 | 156.29 Million CNY | -22.07% |
| 2019 Q1 | 200.55 Million CNY | 407.78% |
| 2019 Q3 | 146.18 Million CNY | -6.47% |
| 2019 Q4 | -16.25 Million CNY | -111.12% |
| 2018 Q2 | 167.81 Million CNY | -7.98% |
| 2018 Q4 | 39.49 Million CNY | -78.27% |
| 2018 FY | 571.44 Million CNY | 7.1% |
| 2018 Q1 | 182.36 Million CNY | 27.58% |
| 2018 Q3 | 181.77 Million CNY | 8.32% |
| 2017 Q3 | 157.86 Million CNY | 49.4% |
| 2017 Q2 | 105.66 Million CNY | -16.87% |
| 2017 Q1 | 127.1 Million CNY | 33.67% |
| 2017 FY | 533.57 Million CNY | 18.02% |
| 2017 Q4 | 142.94 Million CNY | -9.45% |
| 2016 Q1 | 149.09 Million CNY | 152.37% |
| 2016 FY | 452.1 Million CNY | -21.38% |
| 2016 Q4 | 95.08 Million CNY | -8.1% |
| 2016 Q3 | 103.46 Million CNY | -0.95% |
| 2016 Q2 | 104.45 Million CNY | -29.94% |
| 2015 Q4 | 59.07 Million CNY | -56.84% |
| 2015 Q2 | 200.01 Million CNY | 11.68% |
| 2015 FY | 575.04 Million CNY | -17.27% |
| 2015 Q1 | 179.08 Million CNY | 9.08% |
| 2015 Q3 | 136.86 Million CNY | -31.57% |
| 2014 Q3 | 173.62 Million CNY | -7.86% |
| 2014 Q4 | 164.18 Million CNY | -5.44% |
| 2014 FY | 695.08 Million CNY | 20.38% |
| 2014 Q1 | 168.82 Million CNY | 23.46% |
| 2014 Q2 | 188.44 Million CNY | 11.62% |
| 2013 Q1 | 129.03 Million CNY | -1.93% |
| 2013 Q3 | 148.93 Million CNY | -8.45% |
| 2013 Q4 | 136.75 Million CNY | -8.18% |
| 2013 FY | 577.39 Million CNY | 20.04% |
| 2013 Q2 | 162.67 Million CNY | 26.08% |
| 2012 Q2 | 124.71 Million CNY | 26.93% |
| 2012 Q1 | 98.25 Million CNY | 17.56% |
| 2012 Q4 | 131.57 Million CNY | 4.04% |
| 2012 FY | 481.01 Million CNY | -8.09% |
| 2012 Q3 | 126.46 Million CNY | 1.41% |
| 2011 FY | 523.34 Million CNY | 91.9% |
| 2011 Q4 | 83.57 Million CNY | -7.4% |
| 2011 Q3 | 90.26 Million CNY | -67.1% |
| 2011 Q1 | 75.15 Million CNY | -1.99% |
| 2011 Q2 | 274.34 Million CNY | 265.02% |
| 2010 Q1 | 56.16 Million CNY | 3.04% |
| 2010 FY | 272.71 Million CNY | 11.72% |
| 2010 Q2 | 78.57 Million CNY | 39.9% |
| 2010 Q3 | 61.29 Million CNY | -21.99% |
| 2010 Q4 | 76.68 Million CNY | 25.1% |
| 2009 FY | 244.1 Million CNY | 12.05% |
| 2009 Q4 | 54.5 Million CNY | -23.48% |
| 2009 Q3 | 71.22 Million CNY | -0.58% |
| 2009 Q2 | 71.64 Million CNY | 53.34% |
| 2009 Q1 | 46.72 Million CNY | -18.74% |
| 2008 Q4 | 57.49 Million CNY | -10.34% |
| 2008 Q3 | 64.12 Million CNY | 3.65% |
| 2008 Q2 | 61.86 Million CNY | 80.04% |
| 2008 Q1 | 34.36 Million CNY | -17.8% |
| 2008 FY | 217.85 Million CNY | 61.62% |
| 2007 Q1 | 21.75 Million CNY | 39.1% |
| 2007 FY | 134.8 Million CNY | 167.88% |
| 2007 Q4 | 41.8 Million CNY | 3.34% |
| 2007 Q3 | 40.45 Million CNY | 31.4% |
| 2007 Q2 | 30.78 Million CNY | 41.5% |
| 2006 Q1 | 9.04 Million CNY | 49.43% |
| 2006 Q2 | 11.55 Million CNY | 27.79% |
| 2006 FY | 50.32 Million CNY | 48.78% |
| 2006 Q3 | 14.08 Million CNY | 21.89% |
| 2006 Q4 | 15.64 Million CNY | 11.06% |
| 2005 Q1 | 6.4 Million CNY | -29.95% |
| 2005 Q2 | 9.09 Million CNY | 42.05% |
| 2005 FY | 33.82 Million CNY | 5.68% |
| 2005 Q3 | 12.27 Million CNY | 34.89% |
| 2005 Q4 | 6.05 Million CNY | -50.69% |
| 2004 Q3 | 9.49 Million CNY | 29.77% |
| 2004 Q2 | 7.32 Million CNY | 21.19% |
| 2004 Q4 | 9.14 Million CNY | -3.78% |
| 2004 FY | 32 Million CNY | 2.57% |
| 2004 Q1 | 6.04 Million CNY | -38.86% |
| 2003 Q4 | 9.87 Million CNY | 37.25% |
| 2003 FY | 31.19 Million CNY | 61.71% |
| 2003 Q3 | 7.19 Million CNY | 0.0% |
| 2002 FY | 19.29 Million CNY | 2.06% |
| 2001 FY | 18.9 Million CNY | 0.0% |